These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 31207322

  • 1. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT.
    Fan X, Song J, Zhao Z, Chen M, Tu J, Lu C, Wu F, Zhang D, Weng Q, Zheng L, Xu M, Ji J.
    Cancer Lett; 2019 Sep 28; 460():119-127. PubMed ID: 31207322
    [Abstract] [Full Text] [Related]

  • 2. H19-Wnt/β-catenin regulatory axis mediates the suppressive effects of apigenin on tumor growth in hepatocellular carcinoma.
    Pan FF, Zheng YB, Shi CJ, Zhang FW, Zhang JF, Fu WM.
    Eur J Pharmacol; 2021 Feb 15; 893():173810. PubMed ID: 33345859
    [Abstract] [Full Text] [Related]

  • 3. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH, Zhang YF, Xu ZD, Z H L, Y F Z, Z D X.
    J BUON; 2018 Feb 15; 23(6):1717-1724. PubMed ID: 30610799
    [Abstract] [Full Text] [Related]

  • 4. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 5. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 6. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T, Zhu X, Zhu K, Jia F, Li S.
    Cancer Biol Ther; 2019 Feb 28; 20(7):1007-1016. PubMed ID: 30929558
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 28; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 8. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J, Wang D, Wang Z, Tian W, Li X, Duan J, Wang Y, Yang H, You L, Cheng Y, Bian J, Chen Z, Yang Y.
    Cancer Lett; 2016 Sep 28; 380(1):134-43. PubMed ID: 27349166
    [Abstract] [Full Text] [Related]

  • 9. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
    Cheng Z, Yuan X, Qu Y, Li X, Wu G, Li C, Zu X, Yang N, Ke X, Zhou J, Xie N, Xu X, Liu S, Shen Y, Li H, Zhang W.
    Cancer Lett; 2017 Sep 10; 403():195-205. PubMed ID: 28645563
    [Abstract] [Full Text] [Related]

  • 10. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY, He YH, Chen C, Xu T, Li L, Ni MM, Meng XM, Huang C, Li J.
    Cancer Lett; 2016 Jun 28; 376(1):10-21. PubMed ID: 26975630
    [Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
    Tian X, Wu Y, Yang Y, Wang J, Niu M, Gao S, Qin T, Bao D.
    Mol Oncol; 2020 Feb 28; 14(2):462-483. PubMed ID: 31785055
    [Abstract] [Full Text] [Related]

  • 12. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z, Zhang Y, Xu Z.
    J BUON; 2018 Feb 28; 23(1):188-192. PubMed ID: 29552782
    [Abstract] [Full Text] [Related]

  • 13. Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.
    Cheng X, Tian P, Zheng W, Yan X.
    Cancer Med; 2020 Jun 28; 9(12):4265-4273. PubMed ID: 32281302
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH, Feng WC, Lu LC, Shao YY, Hsu CH, Cheng AL.
    Cancer Lett; 2016 Oct 10; 381(1):58-66. PubMed ID: 27431312
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway.
    Wang XL, Shi M, Xiang T, Bu YZ.
    J Cell Biochem; 2019 Jan 10; 120(1):275-282. PubMed ID: 30230592
    [Abstract] [Full Text] [Related]

  • 16. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J, Liu L, Zou H, Yu W.
    Yonsei Med J; 2019 Oct 10; 60(10):905-913. PubMed ID: 31538425
    [Abstract] [Full Text] [Related]

  • 17. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K, Li C, Zhang X, Shang L.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30996112
    [Abstract] [Full Text] [Related]

  • 18. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F, Yin LX.
    Exp Mol Pathol; 2019 Feb 31; 106():34-43. PubMed ID: 30539797
    [Abstract] [Full Text] [Related]

  • 19. Urolithin B suppresses tumor growth in hepatocellular carcinoma through inducing the inactivation of Wnt/β-catenin signaling.
    Lv MY, Shi CJ, Pan FF, Shao J, Feng L, Chen G, Ou C, Zhang JF, Fu WM.
    J Cell Biochem; 2019 Oct 31; 120(10):17273-17282. PubMed ID: 31218741
    [Abstract] [Full Text] [Related]

  • 20. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.
    Xu MX, Zhao L, Deng C, Yang L, Wang Y, Guo T, Li L, Lin J, Zhang L.
    Int J Oncol; 2013 Dec 31; 43(6):1951-9. PubMed ID: 24064724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.